Rainer Boehm
Director/Board Member bij CELLECTIS S.A.
Vermogen: 8 $ op 29-02-2024
Profiel
Founder of Rainer Boehm GmbH, Rainer Boehm is Chairman at Berlin Cures Holding AG.
Dr. Boehm is also on the board of Humanigen, Inc., Cellectis SA, Omega Therapeutics, Inc. and BioCopy AG and Owner at Rainer Boehm GmbH.
In his past career Dr. Boehm occupied the position of Chief Commercial & Medical Officer at Novartis Pharma SAS, Chief Commercial & Medical Affairs Officer at Novartis Pharma Schweiz AG and Executive Vice President-North America at Novartis Oncology, Inc.
He received an MBA from Schiller International University (France) and a doctorate from Universität Ulm.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
HUMANIGEN INC
0.07% | 11-04-2023 | 84 986 ( 0.07% ) | 8 $ | 29-02-2024 |
CELLECTIS SA
-.--% | 14-02-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
OMEGA THERAPEUTICS, INC.
-.--% | 11-04-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Rainer Boehm
Bedrijven | Functie | Begin |
---|---|---|
CELLECTIS S.A. | Director/Board Member | 29-06-2017 |
HUMANIGEN, INC. | Director/Board Member | 12-02-2018 |
OMEGA THERAPEUTICS, INC. | Director/Board Member | 01-09-2022 |
Rainer Boehm GmbH | Founder | - |
BioCopy AG | Director/Board Member | 01-02-2020 |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The private company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Chairman | - |
Eerdere bekende functies van Rainer Boehm
Bedrijven | Functie | Einde |
---|---|---|
THOR MEDICAL | Director/Board Member | 28-04-2022 |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-01-2010 |
░░░░░░░░ ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Opleiding van Rainer Boehm
Universität Ulm | Doctorate Degree |
Schiller International University (France) | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
HUMANIGEN, INC. | Health Technology |
CELLECTIS S.A. | Health Technology |
OMEGA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Health Technology |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The private company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Health Technology |
Rainer Boehm GmbH | |
BioCopy AG |